FRANCESCHINI, Erica
 Distribuzione geografica
Continente #
NA - Nord America 9.769
AS - Asia 5.947
EU - Europa 5.813
SA - Sud America 939
AF - Africa 169
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.666
Nazione #
US - Stati Uniti d'America 9.465
IT - Italia 1.914
SG - Singapore 1.879
CN - Cina 1.483
GB - Regno Unito 1.246
VN - Vietnam 788
HK - Hong Kong 697
BR - Brasile 671
DE - Germania 611
SE - Svezia 438
RU - Federazione Russa 340
FI - Finlandia 295
FR - Francia 274
KR - Corea 203
CA - Canada 185
ID - Indonesia 157
IN - India 143
NL - Olanda 118
TR - Turchia 106
AR - Argentina 93
BD - Bangladesh 86
MX - Messico 76
UA - Ucraina 75
BG - Bulgaria 70
ES - Italia 67
JP - Giappone 61
PL - Polonia 56
LT - Lituania 51
IQ - Iraq 50
ZA - Sudafrica 45
CO - Colombia 44
PK - Pakistan 38
AE - Emirati Arabi Uniti 37
IE - Irlanda 33
AT - Austria 31
EC - Ecuador 30
SI - Slovenia 29
CL - Cile 28
CZ - Repubblica Ceca 28
MA - Marocco 28
BE - Belgio 26
VE - Venezuela 23
CH - Svizzera 20
MY - Malesia 20
AU - Australia 18
IR - Iran 18
PY - Paraguay 18
UZ - Uzbekistan 18
EG - Egitto 17
NP - Nepal 16
PE - Perù 16
SA - Arabia Saudita 16
PH - Filippine 15
IL - Israele 12
JO - Giordania 12
TH - Thailandia 12
TN - Tunisia 12
KE - Kenya 11
TW - Taiwan 11
AZ - Azerbaigian 10
DZ - Algeria 10
RO - Romania 10
CR - Costa Rica 9
ET - Etiopia 9
GR - Grecia 9
KZ - Kazakistan 9
OM - Oman 9
SN - Senegal 9
PA - Panama 8
PT - Portogallo 8
BO - Bolivia 7
GE - Georgia 7
HU - Ungheria 7
LV - Lettonia 7
NG - Nigeria 7
PS - Palestinian Territory 7
UY - Uruguay 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
EE - Estonia 6
JM - Giamaica 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
MK - Macedonia 5
BH - Bahrain 4
CI - Costa d'Avorio 4
MN - Mongolia 4
PR - Porto Rico 4
RS - Serbia 4
SD - Sudan 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
Totale 22.624
Città #
Ashburn 1.254
Singapore 1.193
Santa Clara 1.151
Southend 768
Fairfield 734
Hong Kong 670
San Jose 589
Chandler 575
Hefei 482
Houston 315
Seattle 312
Woodbridge 282
Nyköping 276
London 256
Ho Chi Minh City 240
Beijing 236
Cambridge 236
Wilmington 228
New York 221
Los Angeles 220
Helsinki 219
Seoul 197
Dallas 189
Modena 177
Hanoi 172
Council Bluffs 168
Munich 162
Ann Arbor 147
Chicago 143
Bologna 137
Milan 131
The Dalles 130
Jakarta 122
San Diego 122
Rome 102
Dearborn 98
Lauterbourg 98
Shanghai 89
Moscow 80
Jacksonville 71
Toronto 64
Princeton 63
Sofia 60
São Paulo 60
Frankfurt am Main 55
Orem 55
Buffalo 53
Parma 51
Tokyo 50
Warsaw 49
Bremen 46
Turku 45
Salt Lake City 43
Izmir 40
Redwood City 40
Amsterdam 39
Fremont 39
Da Nang 38
Naples 37
North York 37
Nuremberg 37
Reggio Emilia 37
Haiphong 36
Montreal 36
Phoenix 35
Mexico City 33
Atlanta 31
Stockholm 31
Hillsboro 30
Johannesburg 28
Columbus 27
Brussels 26
Dublin 26
Falls Church 26
Kent 26
Redondo Beach 26
Tampa 26
Chennai 23
Paris 23
Brooklyn 22
Rimini 22
Boardman 21
Des Moines 21
Eugene 21
Rio de Janeiro 21
San Francisco 21
Turin 21
Madrid 20
Mumbai 20
Palermo 20
Poplar 19
Biên Hòa 18
Catania 18
Durham 18
Düsseldorf 18
Elk Grove Village 18
Guangzhou 18
Portsmouth 18
Lappeenranta 17
Baghdad 16
Totale 14.927
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 786
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 459
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 453
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 447
Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy 435
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 421
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 398
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 398
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 365
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 363
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 362
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 361
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 355
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 341
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 338
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 332
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 330
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 321
Hypokalemia in Patients with COVID-19 309
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 297
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 287
Peritoneal dialysis in the time of coronavirus disease 2019 285
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 278
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 274
Metabolic reprograming shapes neutrophil functions in severe COVID-19 274
Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient 269
Engagement and retention in care of patients diagnosed with HIV infection and enrolled in the Modena HIV surveillance cohort. 263
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 263
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 260
Acid base disorders in patients with COVID-19 257
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 255
Should we screen for NAFLD/NASH in HIV patients? 247
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 247
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 245
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 244
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 244
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 244
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 238
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 236
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 234
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 233
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial 231
Characteristics of HIV-infected patients not retained in care of two cohorts of northern Italy. 230
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 225
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 221
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 220
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 217
Not just minor resections: robotic approach for cystic echinococcosis of the liver 216
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 213
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 208
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 202
Death After Liver Transplantation: Mining Interpretable Risk Factors for Survival Prediction 201
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 200
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 198
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: a prospective multicentre study 194
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 192
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 188
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 186
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 185
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 185
AKI in hospitalized patients with COVID-19: a single-center experience 181
Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients 178
Blackwater Fever Treated with Steroids in Nonimmune Patient, Italy 177
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 166
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 166
The WEST Study: A Retrospective and Multicentric Study on the Impact of Steroid Therapy in West Nile Encephalitis 165
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 165
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 164
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit 161
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 157
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 157
Role of Maraviroc in minimizing the risk of graft rejection in HIV-infected kidney transplant recipients 156
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 150
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 150
Central Nervous System Infections Caused by Bacillus Calmette-Guerin: Case Report and Narrative Literature Review 146
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 145
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 145
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 144
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia 143
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection 141
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 137
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 131
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 129
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 129
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study 129
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 125
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 124
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 121
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis 118
Use of colistin in adult patients: A cross-sectional study 114
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 105
Distinct leishmania infantum strains circulate in humans and dogs in the Emilia-Romagna region, northeastern Italy 105
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort study 102
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge—Brief Report and Review of the Literature 93
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy 83
Streptococcus pneumoniae bacteremia: comparison of incidence, epidemiology, and clinical outcome in a pre- and post-COVID-19 period 61
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study 52
Proactive antimicrobial stewardship with real-time microbiological alerts improves management of bloodstream infections 49
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study 46
Totale 22.775
Categoria #
all - tutte 91.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021523 0 0 0 0 0 0 0 0 0 189 180 154
2021/20221.816 141 100 126 79 87 100 205 103 185 146 323 221
2022/20231.969 235 259 176 185 216 244 66 162 187 38 93 108
2023/20241.720 60 93 133 167 295 195 116 178 64 65 130 224
2024/20254.862 144 97 111 323 812 743 415 291 586 235 496 609
2025/20268.733 714 438 783 1.086 1.385 592 1.226 516 981 1.012 0 0
Totale 22.893